Comparing PBMCs from patients with atopic dermatitis pre- and post-treatment with dupilumab
Single-cell RNA-seq · human · 16 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Samples
- 16 samples: 16 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE183953_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA762487 and SRA study SRP336654. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 16 sample titles: 16 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM5574840 PBMCs, AD024-pre_GEX
- GSM5574841 PBMCs, AD024-post_GEX
- GSM5574842 PBMCs, AD035-pre_GEX
- GSM5574843 PBMCs, AD035-post_GEX
- GSM5574844 PBMCs, AD036-pre_GEX
- GSM5574845 PBMCs, AD036-post_GEX
- GSM5574846 PBMCs, AD051-pre_GEX
- GSM5574847 PBMCs, AD051-post_GEX
- GSM5574848 PBMCs, AD024-pre_VDJ
- GSM5574849 PBMCs, AD024-post_VDJ
- GSM5574850 PBMCs, AD035-pre_VDJ
- GSM5574851 PBMCs, AD035-post_VDJ
- GSM5574852 PBMCs, AD036-pre_VDJ
- GSM5574853 PBMCs, AD036-post_VDJ
- GSM5574854 PBMCs, AD051-pre_VDJ
- GSM5574855 PBMCs, AD051-post_VDJ
- GSE208405 RNA-Seq in peripheral blood samples of atopic dermatitis patients of the TREATgermany registry before and after initiation of systemic therapy with Dupilumab 179 samples shares dermatitis, dupilumab, atopic
- GSE326320 Integrative transcriptomic, network, and genomic analysis of peripheral blood mononuclear cells identifies candidate gene drivers of dupilumab clinical response in atopic dermatitis patients 36 samples shares dermatitis, dupilumab, atopic
- GSE130588 Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis 208 samples shares dermatitis, dupilumab, atopic
- GSE59294 Blocking IL-4Rα with dupilumab (REGN668/SAR231893) rapidly suppresses major pathomechanisms in the skin of severe atopic dermatitis patients 40 samples shares dermatitis, dupilumab, atopic
- GSE189188 Comparing PBMCs from patients with different pruritic conditions 40 samples shares comparing, pbmcs
- GSE289784 Safety and Efficacy of Atuzabrutinib Topical Gel in Patients with Mild-to-Moderate Atopic Dermatitis: Findings from Phase 2a Trial 39 samples shares dermatitis, atopic
- GSE330551 Th2-primed innate immune amplification defines a distinct atopic dermatitis endotype 174 samples shares dermatitis, atopic
- GSE277961 Tralokinumab treatment of Atopic dermatitis induces a progressive transcriptomic response 154 samples shares dermatitis, atopic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.